Abstract
Get full access to this article
View all access options for this article.
References
1.Shape Therapeutics and Otsuka Pharmaceutical . Otsuka Collaborates with ShapeTX to Develop Novel AAV Gene Therapies for Ocular Diseases . September 7, 2023 . Available from: https://www.globenewswire.com/news-release/2023/09/07/2739805/0/en/Otsuka-collaborates-with-ShapeTX-to-develop-novel-AAV-gene-therapies-for-ocular-diseases.html [Last accessed: September 14, 2023].
2.Beam Therapeutics . Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL . September 5, 2023 . Available from: https://investors.beamtx.com/news-releases/news-release-details/beam-therapeutics-announces-first-patient-dosed-phase-12-trial [Last accessed: September 15, 2023].
3.Royalty Pharma and Ferring Pharmaceuticals . Royalty Pharma and Ferring Pharmaceuticals Enter into US $500 Million Royalty Agreement for New Intravesical Gene Therapy ADSTILADRIN® (nadofaragene firadenovec-vncg) . August 24, 2023 . Available from: https://www.ferring.com/royalty-pharma-and-ferring-pharmaceuticals-enter-into-us-500-million-royalty-agreement-for-new-intravesical-gene-therapy-ADSTILADRIN/ [Last accessed:
September 14 , 2023
].
4.Syncona . Update on Gyroscope and Associated Milestone Payments . September 11, 2023 . Available from: https://www.synconaltd.com/news-and-insights/news/update-on-gyroscope-and-associated-milestone-payments/ [Last accessed: September 13, 2023].
5.Kriya Therapeutics . Kriya Acquires Tramontane Therapeutics and Launches Gene Therapy Program for Nonalcoholic Steatohepatitis (NASH) and Other Prevalent Diseases . September 6, 2023 . Available from: https://kriyatherapeutics.com/news/kriya-acquires-tramontane-therapeutics-and-launches-gene-therapy-program-for-nonalcoholic-steatohepatitis-nash-and-other-prevalent-diseases/ [Last accessed: September 13, 2023].
6.Rocket Pharmaceuticals . Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease . September 12, 2023 . Available from: https://ir.rocketpharma.com/news-releases/news-release-details/rocket-pharmaceuticals-reaches-fda-alignment-pivotal-phase-2 [Last accessed: September 15, 2023].